devics-syndrome-treatment-market

Devic's Syndrome Treatment Market By Drugs (Eculizumab, Methylprednisolone, Azathioprine, Mycophenolate Mofetil, Rituximab) - Growth, Future Prospects, And Competitive Analysis, 2024 - 2032

01 Dec 2019 Format PDF icon PPT icon XLS icon Request Sample
Choose Licence Type
$4500
$6500
$9000
Why Acute
View Other Reports